FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1566327079> ?p ?o ?g. }

• W1566327079 endingPage "111" @default.
• W1566327079 startingPage "109" @default.
• W1566327079 abstract "From the start of the HIV epidemic, respiratory failure has been the most common indication for patients with HIV infection to be admitted to the intensive care unit (ICU). In the era of highly active antiretroviral therapy (HAART), Pneumocystis jirovecii pneumonia (PCP), bacterial pneumonia and tuberculosis continue to be significant causes of respiratory failure; however, admission to the ICU with non-HIV-associated respiratory causes, including emphysema and asthma, is increasingly encountered [1–3]. An emerging cause of respiratory failure requiring admission to the ICU is immune reconstitution inflammatory syndrome (IRIS) [4]. Non-respiratory causes, including renal and hepatic failure, cardiac disease, drug overdose and severe toxicity from HIV therapy are increasingly recognised [1–4]. Early in the HIV epidemic, HIV-seropositive patients with critical illnesses were deemed incurable. ICU mortality rates were high and long-term survival rates were low [5–7]. The majority of admissions to the ICU were patients with severe PCP. As a direct result of HAART, there has been a sustained reduction in HIV-associated morbidity and mortality. Several studies report improved outcomes for HIV-seropositive patients requiring admission to the ICU in the HAART era [1–3,8,9]. One recent study suggests that outcomes from ICU admission for HIV-seropositive patients are equivalent to those for the general medical (non-HIV-infected) population [3]. HIV-seropositive patients should not be refused ICU admission based merely on the patient's HIV-serostatus (category IV recommendation). Improved survival from HIV-associated PCP after 1996 has been shown to be independent of the use of HAART and likely reflect general improvements in the ICU management of acute lung injury (ALI) [10]. All HIV-seropositive patients with ALI/acute respiratory distress syndrome (ARDS) who are mechanically ventilated should be managed using the same protocols for management of ALI/ARDS as among general populations – with low tidal volumes and controlled plateau pressures, for example using the ARDS Network guidelines [11] (category IV recommendation). It is currently unclear whether starting HAART on the ICU confers improved outcome for HIV-seropositive patients admitted to the ICU [1,3,10]. In such patients, the short-term effect of HIV RNA level and CD4 cell count on mortality is unclear. Among HIV-seropositive patients already in receipt of HAART, there was no apparent improvement in survival when compared with HIV-seropositive patients not taking HAART [3]. The use of HAART in severely unwell HIV-seropositive patients is confounded by several issues, including drug absorption, requirements for dose modification in the presence of intercurrent renal- and hepatic-induced disease, drug–drug interactions (see Table 12.1), HAART-associated toxicity and IRIS. In some circumstances it may be more appropriate to change HIV therapy rather than dose modify. Advice should be sought from an HIV clinician and/or pharmacist prior to planned modification of HAART. Expert daily consultation between HIV and ICU physicians is essential in the management of critically-ill HIV-seropositive patients admitted to the ICU. Additionally, the advice of a pharmacist with expertise of treatment of HIV-associated infection should be sought. In some cases this expertise will be obtained by transfer of the patient to a tertiary centre (category IV recommendation)." @default.
• W1566327079 created "2016-06-24" @default.
• W1566327079 creator A5003772516 @default.
• W1566327079 creator A5022102306 @default.
• W1566327079 creator A5049329206 @default.
• W1566327079 date "2011-08-18" @default.
• W1566327079 modified "2023-10-18" @default.
• W1566327079 title "12 Intensive care" @default.
• W1566327079 cites W1990028629 @default.
• W1566327079 cites W2016095124 @default.
• W1566327079 cites W2026868315 @default.
• W1566327079 cites W2134923759 @default.
• W1566327079 cites W2135595698 @default.
• W1566327079 cites W2142716715 @default.
• W1566327079 cites W2148847506 @default.
• W1566327079 cites W2151433476 @default.
• W1566327079 cites W2597070792 @default.
• W1566327079 doi "https://doi.org/10.1111/j.1468-1293.2011.00944_13.x" @default.
• W1566327079 hasPublicationYear "2011" @default.
• W1566327079 type Work @default.
• W1566327079 sameAs 1566327079 @default.
• W1566327079 citedByCount "0" @default.
• W1566327079 crossrefType "journal-article" @default.
• W1566327079 hasAuthorship W1566327079A5003772516 @default.
• W1566327079 hasAuthorship W1566327079A5022102306 @default.
• W1566327079 hasAuthorship W1566327079A5049329206 @default.
• W1566327079 hasBestOaLocation W15663270791 @default.
• W1566327079 hasConcept C126322002 @default.
• W1566327079 hasConcept C142462285 @default.
• W1566327079 hasConcept C177713679 @default.
• W1566327079 hasConcept C187212893 @default.
• W1566327079 hasConcept C203014093 @default.
• W1566327079 hasConcept C2776348555 @default.
• W1566327079 hasConcept C2776376669 @default.
• W1566327079 hasConcept C2776535787 @default.
• W1566327079 hasConcept C2776888751 @default.
• W1566327079 hasConcept C2777714996 @default.
• W1566327079 hasConcept C2777914695 @default.
• W1566327079 hasConcept C2908647359 @default.
• W1566327079 hasConcept C3013748606 @default.
• W1566327079 hasConcept C71924100 @default.
• W1566327079 hasConcept C99454951 @default.
• W1566327079 hasConceptScore W1566327079C126322002 @default.
• W1566327079 hasConceptScore W1566327079C142462285 @default.
• W1566327079 hasConceptScore W1566327079C177713679 @default.
• W1566327079 hasConceptScore W1566327079C187212893 @default.
• W1566327079 hasConceptScore W1566327079C203014093 @default.
• W1566327079 hasConceptScore W1566327079C2776348555 @default.
• W1566327079 hasConceptScore W1566327079C2776376669 @default.
• W1566327079 hasConceptScore W1566327079C2776535787 @default.
• W1566327079 hasConceptScore W1566327079C2776888751 @default.
• W1566327079 hasConceptScore W1566327079C2777714996 @default.
• W1566327079 hasConceptScore W1566327079C2777914695 @default.
• W1566327079 hasConceptScore W1566327079C2908647359 @default.
• W1566327079 hasConceptScore W1566327079C3013748606 @default.
• W1566327079 hasConceptScore W1566327079C71924100 @default.
• W1566327079 hasConceptScore W1566327079C99454951 @default.
• W1566327079 hasIssue "s2" @default.
• W1566327079 hasLocation W15663270791 @default.
• W1566327079 hasOpenAccess W1566327079 @default.
• W1566327079 hasPrimaryLocation W15663270791 @default.
• W1566327079 hasRelatedWork W160291598 @default.
• W1566327079 hasRelatedWork W1999437375 @default.
• W1566327079 hasRelatedWork W2000956038 @default.
• W1566327079 hasRelatedWork W2795151333 @default.
• W1566327079 hasRelatedWork W2810184270 @default.
• W1566327079 hasRelatedWork W3034889157 @default.
• W1566327079 hasRelatedWork W3129568388 @default.
• W1566327079 hasRelatedWork W4244652115 @default.
• W1566327079 hasRelatedWork W4256211532 @default.
• W1566327079 hasRelatedWork W4382239339 @default.
• W1566327079 hasVolume "12" @default.
• W1566327079 isParatext "false" @default.
• W1566327079 isRetracted "false" @default.
• W1566327079 magId "1566327079" @default.
• W1566327079 workType "article" @default.